We are excited to welcome you to this year's Awareness Lectures on Psychedelic Science. Once again, leading scientists and clinicians from around the world will come together to share their knowledge on the many facets of psychedelic research and therapy.
This year's conference will explore the cutting-edge developments in the field of psychedelic science, with a focus on innovative therapeutic applications, ground-breaking research, and the potential for these substances to transform our understanding of consciousness and the human experience.
In addition to 14 talks, we'll have two panel discussions.
Friday panel: Contemporary Issues in Policy, Regulation, and Access
Join us for a panel discussion on contemporary issues in policy, regulation, and access. The panel will feature Tadeusz Hawrot, representing the Psychedelic Access and Research European Alliance (PAREA), and Prof. Mathias Liechti. The other speakers are yet to be announced.
Saturday panel: MDMA-Assisted Psychotherapy: Past, Present, and Future Perspectives
This panel is titled “MDMA-assisted psychotherapy: past, present, and future perspectives.” It will be a unique moment in history and will feature some of the most prominent figures in the field of MDMA-assisted psychotherapy. The panelists include Rick Doblin, Peter Oehen, Michael Mithoefer
On Friday evening, we will screen Dosed 2: The Trip of a Lifetime
This moving and inspiring documentary follows Laurie, a woman with terminal cancer, as she uses psilocybin-assisted therapy to cope with her diagnosis and make peace with her own death. Laurie's journey is one of courage, hope, and transformation.
With the support of her loving family, she embarks on a psychedelic journey that helps her to connect with her inner strength, find acceptance, and discover a new appreciation for life.
On Saturday evening, we invite all participants to join us for our Networking Apéro
Where you will have the opportunity to connect with other attendees and speakers, share your own experiences, and engage in meaningful discussions.
We are also excited to announce that this year we will have a research poster session, providing an opportunity for attendees to showcase their own research and learn about the latest findings in the field.
The Array Infinitive project by Leslie Deere.
This PhD project explore the audio-visuals in VR as an altered-state experience.
During the conference, you will have the chance to try the The Array Infinitive project. This work draws upon ambient audio and colourful visuals generated, processed, and ‘played’ via gesture, creating a shared group experience, through sound, colour and movement. As the performer moves around, ribbons of colourful particle trails are produced. The visuals swirl and unfurl, in tandem with soundscapes. Each bodily gesture activates different sounds, which are mixed together through movement. The piece becomes an instrument. The conductor becomes a conduit. The tempo is slow and the atmosphere is meditative.
Following on from the official programme at Breaking Convention 2023, for the ALPs Conference, Array Infinitive will be installed next to the chillout area and welcomes participants to interact, dive-in and speak about the research.
This PhD research has taken place at the Glasgow School of Art (2017-2023), with supervision and consultation from Dr David Luke (University of Greenwich), Dr Francis McKee (Director CCA Glasgow), Ronan Breslin (LaChunky Studios Glasgow), Dr Marianne Greater (GSA) and Dr James Hutchinson (GSA).
You will also have the opportunity to try the RoXiva Psychedelic Lamp. The lamp will blow your mind in a good way, and will help you completely let go into a blissful world of colourful, moving kaleidoscopic patterns synchronised to music.
Having this kind of drug free access to psychedelic states opens doorways to both entertainment and psychedelic light therapy uses.
Attending ALPS Conference provides
21 ECTS for Psychologists (FSP)
10 ECTS for Medical Doctors (SSPP)
Meet the speakers
Last Year's Aftermovie
MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes.
They are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.
Based in Liechtenstein, the Mycoverse Foundation was launched in 2022 with the mission to promote and disseminate knowledge about mushrooms and their properties among the public. While mycology and foraging are traditionally associated with the study of mushrooms, the Mycoverse foundation will dedicate its focus on researching and developing cutting-edge technologies derived from mushrooms’ properties. From domains as diverse as agriculture and sustainable food production (with recent developments such as meat alternative) to medical treatments, to mycoremediation (soil depollution and water filtration), to gastronomy, to construction materials (soundproofing), leather-replacement or bio-pesticides, the applications derived from mushrooms are limitless.
Get in touch with us